CN115125295A - Genotyping standard substance for multi-site sustainable use - Google Patents
Genotyping standard substance for multi-site sustainable use Download PDFInfo
- Publication number
- CN115125295A CN115125295A CN202210230210.4A CN202210230210A CN115125295A CN 115125295 A CN115125295 A CN 115125295A CN 202210230210 A CN202210230210 A CN 202210230210A CN 115125295 A CN115125295 A CN 115125295A
- Authority
- CN
- China
- Prior art keywords
- standard
- ptc
- hex
- genotyping
- snp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003205 genotyping method Methods 0.000 title claims abstract description 28
- 239000000126 substance Substances 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 32
- 102200108199 rs1042522 Human genes 0.000 claims abstract description 25
- 238000002360 preparation method Methods 0.000 abstract description 15
- 238000012408 PCR amplification Methods 0.000 abstract description 12
- 238000012163 sequencing technique Methods 0.000 abstract description 4
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 74
- 239000000523 sample Substances 0.000 description 28
- 239000011324 bead Substances 0.000 description 20
- 238000001514 detection method Methods 0.000 description 19
- 238000000746 purification Methods 0.000 description 13
- 230000003321 amplification Effects 0.000 description 10
- 238000003199 nucleic acid amplification method Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 238000012795 verification Methods 0.000 description 6
- 238000013461 design Methods 0.000 description 5
- 238000003753 real-time PCR Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000003908 quality control method Methods 0.000 description 4
- 230000004544 DNA amplification Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明属于基因测序标准品技术领域,提供一种用于多位点可持续使用的基因分型标准品,所述标准品包括PTC‑HEX、PTC‑FAM和PTC‑H;其中,PTC‑HEX的PCR产物包括rs25487(G)、rs1042522(C)和rs1048943(A);PTC‑FAM的PCR产物包括rs25487(A)、rs1042522(G)和rs1048943(T),PTC‑H的PCR产物包括PTC‑HEX。本标准品经DNA结构改造,可用于多位点SNP分型,可持续使用的基因分型标准品。可通过单引物PCR扩增的方式进行标准品复制,从而使标准品可持续使用,且大大降低了标准品重新制备的成本。
The invention belongs to the technical field of gene sequencing standard products, and provides a genotyping standard product for multi-site sustainable use, the standard product includes PTC-HEX, PTC-FAM and PTC-H; wherein, PTC-HEX The PCR products of PTC-FAM include rs25487(G), rs1042522(C) and rs1048943(A); the PCR products of PTC‑FAM include rs25487(A), rs1042522(G) and rs1048943(T), and the PCR products of PTC‑H include PTC‑ HEX. This standard is a genotyping standard that can be used for multi-locus SNP typing after DNA structure modification. The standard can be replicated by single-primer PCR amplification, so that the standard can be used sustainably and the cost of standard preparation can be greatly reduced.
Description
技术领域technical field
本发明属于分子生物学技术基因分型领域,具体公开了一种适用于多位点基因分型的标准品。The invention belongs to the field of molecular biology technology genotyping, and specifically discloses a standard product suitable for multi-locus genotyping.
背景技术Background technique
SNP(Single nucleotide polymorphism)即单核苷酸多态性,是基因组DNA中特定核苷酸位置的单个碱基的转化、转位、插入或缺失引起的点突变,导致群体和个体之间产生差异。随着测序技术和生信分析的快速发展,海量的基因组学数据为SNP分子标记奠定了基础,数以万计的SNP多态性位点正在被不断发掘,并广泛应用于遗传疾病诊断、致病候选基因研究、药物筛选研究、分子标记辅助育种、群体遗传研究等。因此对SNP标记的真实性验证、后续开发利用等变得尤为重要。SNP (Single nucleotide polymorphism) is a single nucleotide polymorphism, which is a point mutation caused by the transformation, translocation, insertion or deletion of a single base at a specific nucleotide position in the genomic DNA, resulting in differences between groups and individuals . With the rapid development of sequencing technology and bioinformatics analysis, massive genomics data has laid the foundation for SNP molecular markers, and tens of thousands of SNP polymorphisms are being continuously discovered and widely used in the diagnosis of genetic diseases, pathogenic Disease candidate gene research, drug screening research, molecular marker-assisted breeding, population genetic research, etc. Therefore, the authenticity verification and subsequent development and utilization of SNP markers have become particularly important.
常见的SNP位点一般有两种等位基因,又称双等位基因。因此在群体中,每个个体的一个SNP位点一般存在3种基因型:突变前位点的基因型(纯合型1)、突变后位点的基因型(纯合型2)、突变前后位点基因型共存(杂合型)。通常通过SNP检测技术,确定每个个体的每个SNP位点的基因型属于以上三种基因型中的哪一种。常见的SNP的检测平台有3种:高通量测序平台,中通量基因芯片检测平台,底通量电泳检测平台、荧光定量PCR的检测平台、酶标检测平台等。其中低通量SNP检测平台应用最为广泛和普及。Common SNP loci generally have two alleles, also known as bialleles. Therefore, in a population, there are generally three genotypes at a SNP site of each individual: the genotype of the pre-mutation site (homozygous 1), the genotype of the post-mutation site (homozygous 2), the genotype of the site before and after the mutation Coexistence of loci genotypes (heterozygous). Usually through SNP detection technology, it is determined which of the above three genotypes the genotype of each SNP site of each individual belongs to. There are three common SNP detection platforms: high-throughput sequencing platform, medium-throughput gene chip detection platform, bottom-throughput electrophoresis detection platform, fluorescence quantitative PCR detection platform, enzyme label detection platform, etc. Among them, the low-throughput SNP detection platform is the most widely used and popular.
发明内容SUMMARY OF THE INVENTION
低通量SNP检测平台往往需要每个SNP位点的3种基因型的标准品做参考辅助SNP检测。常见的SNP检测标准品有两种:一种从已知基因型样本中筛选出3种基因型样本,做为标准品;另一种是合成已知基因型的基因序列,作为标准品。但这两种标准品面对多位点SNP检测时均存在其弊端:前者由于每个SNP位点需要3种基因型的标准品,导致多位点SNP的标准品,管数众多,存在存储困难,取用易出错等问题;且每一批次标准品使用完后,需重新采样,提取DNA制备标准品,可能存在样本重新获取困难的问题,且增加了DNA提取成本。后者基因合成成本高,尤其是多位点基因合成本更加高昂,标准品使用完后,需再次进行高成本基因合成。Low-throughput SNP detection platforms often require 3 genotype standards for each SNP locus for reference-assisted SNP detection. There are two common SNP detection standards: one is to select 3 genotype samples from known genotype samples as the standard; the other is to synthesize the gene sequence of the known genotype as the standard. However, these two standards have their drawbacks in multi-locus SNP detection: the former requires 3 genotypes of standards for each SNP locus, resulting in a large number of tubes for multi-locus SNP standards and storage It is difficult to obtain and error-prone; and after each batch of standard products is used, it is necessary to resample and extract DNA to prepare standard products, which may cause difficulties in re-obtaining samples and increase the cost of DNA extraction. The latter gene synthesis cost is high, especially the multi-site gene synthesis cost is even higher. After the standard product is used, high-cost gene synthesis needs to be carried out again.
本发明针对现有SNP标准品的不足,力求开发一种低成本,可用于多位点SNP分型,可持续使用的基因分型标准品,且该标准品一套只有3管,易于保存。Aiming at the deficiencies of the existing SNP standard products, the present invention strives to develop a low-cost, sustainable genotyping standard product that can be used for multi-site SNP typing.
一种用于多位点可持续使用的基因分型标准品,包括PTC-HEX、PTC-FAM和PTC-H;其中,PTC-HEX的PCR产物包括rs25487(G)、rs1042522(C)和rs1048943(A);PTC-FAM的PCR产物包括rs25487(A)、rs1042522(G)和rs1048943(T),PTC-H的PCR产物包括PTC-HEX,其中:A genotyping standard for sustainable use at multiple sites, including PTC-HEX, PTC-FAM and PTC-H; wherein the PCR products of PTC-HEX include rs25487(G), rs1042522(C) and rs1048943 (A); The PCR products of PTC-FAM include rs25487(A), rs1042522(G) and rs1048943(T), and the PCR products of PTC-H include PTC-HEX, wherein:
所述rs25487(G)的基因序列为:5'-[HEX]CGGCTGCCCTCCCGGAGGTAAG[BHQ1];The gene sequence of the rs25487(G) is: 5'-[HEX]CGGCTGCCCTCCCGGAGGTAAG[BHQ1];
所述rs1042522(C)的基因序列为:5'-[HEX]CTGCTCCCCCCGTGGCCCC[BHQ1];The gene sequence of the rs1042522(C) is: 5'-[HEX]CTGCTCCCCCCCGTGGCCCC[BHQ1];
所述rs1048943(A)的基因序列为:5'-[HEX]CGGTGAGACCATTGCCCGCT[BHQ1];The gene sequence of the rs1048943(A) is: 5'-[HEX]CGGTGAGACATTGCCCGCT[BHQ1];
所述rs25487(A)的基因序列为:5'-[6FAM]CGGCTGCCCTCCCAGAGGTAAG[BHQ1];The gene sequence of the rs25487(A) is: 5'-[6FAM]CGGCTGCCCTCCCAGAGGTAAG[BHQ1];
所述rs1042522(G)的基因序列为:5'-[6FAM]CTGCTCCCCGCGTGGCCCC[BHQ1];The gene sequence of the rs1042522(G) is: 5'-[6FAM]CTGCTCCCCGCGTGGCCCC[BHQ1];
所述rs1048943(T)的基因序列为:5'-[6FAM]CGGTGAGACCGTTGCCCGCT[BHQ1]。The gene sequence of rs1048943(T) is: 5'-[6FAM]CGGTGAGACCGTTGCCCGCT[BHQ1].
其中,所述rs25487(G)的浓度为52.2~65.3ng/μL,rs1042522(C)的浓度为59.5~74ng/μL,rs1048943(A)的浓度为47~82.1ng/μL,rs25487(A)的浓度为48.1~53.2ng/μL,rs1042522(G)的浓度为53.2~59.5ng/μL,rs1048943(T)的浓度为42.9~69.6ng/μL,PTC-HEX的浓度为52.4~73.2ng/μL,PTC-HEX的浓度为47.7~60ng/μL;Among them, the concentration of rs25487(G) is 52.2-65.3ng/μL, the concentration of rs1042522(C) is 59.5-74ng/μL, the concentration of rs1048943(A) is 47-82.1ng/μL, and the concentration of rs25487(A) is 59.5-74ng/μL. The concentration of rs1042522(G) was 53.2-59.5ng/μL, the concentration of rs1048943(T) was 42.9-69.6ng/μL, the concentration of PTC-HEX was 52.4-73.2ng/μL, The concentration of PTC-HEX is 47.7~60ng/μL;
其中,所述基因分型标准品用于同时连续检测三个SNP位点,其名称分别为rs25487(G/A)、rs1042522(C/G)、rs1048943(A/G)。Wherein, the genotyping standard is used to simultaneously and continuously detect three SNP sites, whose names are respectively rs25487(G/A), rs1042522(C/G), and rs1048943(A/G).
有益效果beneficial effect
低通量SNP检测平台往往需要每个SNP位点的3种基因型的标准品做参考辅助SNP检测。常见的SNP检测标准品有两种:一种从已知基因型样本中筛选出3种基因型样本,做为标准品;另一种是合成已知基因型的基因序列,作为标准品。但这两种标准品面对多位点SNP检测时均存在其弊端:前者由于每个SNP位点需要3种基因型的标准品,导致多位点SNP的标准品,管数众多,存在存储困难,取用易出错等问题;且每一批次标准品使用完后,需重新采样,提取DNA制备标准品,可能存在样本重新获取困难的问题,且增加了DNA提取成本。后者基因合成成本高,尤其是多位点基因合成本更加高昂,标准品使用完后,需再次进行高成本基因合成。为了解决以上提及的现存问题,我们开发了一种用于多位点可持续使用的基因分型标准品。该发明具有三大优势:其一:该发明基于标准品制备成本考虑,针对不同SNP位点数,给出了标准品,从而大大降低了标准品制备成本。其二:新型标准品一套只有3管,每管融合了每个SNP位点的一种基因型,易于保存,且适用于多位点SNP检测。其三:新型标准品经DNA结构改造,可通过单引物PCR扩增的方式进行标准品复制,从而使标准品可持续使用,且大大降低了标准品重新制备的成本。Low-throughput SNP detection platforms often require 3 genotype standards for each SNP locus for reference-assisted SNP detection. There are two common SNP detection standards: one is to select 3 genotype samples from known genotype samples as the standard; the other is to synthesize the gene sequence of the known genotype as the standard. However, these two standards have their drawbacks in multi-locus SNP detection: the former requires 3 genotypes of standards for each SNP locus, resulting in a large number of tubes for multi-locus SNP standards and storage It is difficult to obtain and error-prone; and after each batch of standard products is used, it is necessary to resample and extract DNA to prepare standard products, which may cause difficulties in re-obtaining samples and increase the cost of DNA extraction. The latter gene synthesis cost is high, especially the multi-site gene synthesis cost is even higher. After the standard product is used, high-cost gene synthesis needs to be carried out again. To address the existing problems mentioned above, we have developed a genotyping standard for sustainable use at multiple loci. The invention has three major advantages: firstly: based on the consideration of the preparation cost of the standard product, the invention provides the standard product according to the number of different SNP sites, thereby greatly reducing the preparation cost of the standard product. Second: a set of new standard products has only 3 tubes, each tube fuses a genotype of each SNP locus, which is easy to store and suitable for multi-locus SNP detection. Third: The new standard product is modified by DNA structure, and the standard product can be replicated by single-primer PCR amplification, so that the standard product can be used sustainably and greatly reduces the cost of standard product re-preparation.
附图说明Description of drawings
图1:实施例1标准品基因分型验证结果。Figure 1: The results of the genotyping verification of the standard product of Example 1.
图2:Illumina平台测序常用接头序列。Figure 2: Commonly used adapter sequences for sequencing on the Illumina platform.
图3:实施例2标准品基因分型验证结果。Figure 3: The results of the genotyping verification of the standard product of Example 2.
具体实施方式Detailed ways
为了使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解,下面结合具体,进一步阐明本发明。In order to make the technical means, creation features, achievement goals and effects of the present invention easy to understand and understand, the present invention will be further explained below in conjunction with the specifics.
本发明中所有的原料,对其来源没有特别限定,在市场上购买的或按照本领域技术人员熟知的常规方法制备的即可。本发明中所有的原料,对其纯度没有特别限定,本发明优选采用分析纯或复合材料领域使用的常规纯度。All the raw materials in the present invention, their sources are not particularly limited, can be purchased in the market or prepared according to conventional methods well known to those skilled in the art. All raw materials in the present invention are not particularly limited in their purity, and the present invention preferably adopts analytical purity or conventional purity used in the field of composite materials.
实施例选用市面上“抑癌卫视”基因分型检测产品进行详细说明。“抑癌卫视”基因分型检测产品包含三个SNP位点,其名称(基因型)分别为rs25487(G/A)、rs1042522(C/G)、rs1048943(A/G)。In the embodiment, the genotyping detection product of "Cancer Suppression Satellite TV" on the market is selected for detailed description. The genotyping test product of "Tumor Suppressor Satellite TV" contains three SNP loci, whose names (genotypes) are rs25487 (G/A), rs1042522 (C/G), and rs1048943 (A/G).
基于成本考虑,5个及5个以下SNP位点的标准品制备,优选实施例1;5个以上SNP位点的标准品制备,优选实施例2。Based on cost considerations, Example 1 is preferred for the preparation of standards with 5 or less SNP sites; Example 2 is preferred for the preparation of standards with more than 5 SNP sites.
实施例1Example 1
1.SNP位点引物设计1. SNP site primer design
引物设计,可直接采用TaqMan探针或其他基于荧光定量PCR的检测平台探针产品自带的引物序列为基础(表1),在其5’端添加统一扩增引物序列(表2)。也可通过rs号,获取其基因序列,使用引物设计软件或网站自行设计引物,并在设计好的引物序列,5’端添加统一扩增引物序列(表2)。The primer design can be based on the TaqMan probe or the primer sequences that come with the probe products of other fluorescent quantitative PCR-based detection platforms (Table 1), and a unified amplification primer sequence (Table 2) is added to the 5' end. It is also possible to obtain the gene sequence through the rs number, use the primer design software or website to design primers, and add the unified amplification primer sequence to the 5' end of the designed primer sequence (Table 2).
本实施例采用ThermoFisher TaqMan探针进行实验,引物直接选用ThermoFisherTaqMan探针产品自带的引物序列,在其5’端添加统一扩增引物序列。信息如下:In this example, the ThermoFisher TaqMan probe was used for the experiment. The primers were directly selected from the primer sequences of the ThermoFisher TaqMan probe products, and a unified amplification primer sequence was added to the 5' end. Message as follows:
表1:ThermoFisher TaqMan探针产品自带引物探针序列信息表Table 1: ThermoFisher TaqMan probe product comes with primer probe sequence information table
表2:5’端添加标准品制备通用引物序列的融合引物信息表Table 2: Fusion primer information table for preparing universal primer sequences by adding standards at the 5' end
2.样本准备2. Sample Preparation
三个SNP位点,每个SNP位点,各准备2种纯合基因型的样本,样本信息如下。Three SNP loci, for each SNP locus, prepare two samples of homozygous genotypes. The sample information is as follows.
表3:样本信息表Table 3: Sample Information Sheet
3.SNP序列扩增3. SNP sequence amplification
使用对应的PCR扩增引物,分别将样本的SNP基因序列扩增下来,并进行0.8X磁珠纯化。完成纯化后,扩增产物名称与表1基因型名称一致。使用Qubit3.0仪器检测扩增产物DNA含量。Using the corresponding PCR amplification primers, the SNP gene sequences of the samples were amplified respectively, and purified by 0.8X magnetic beads. After purification, the names of the amplified products were consistent with the genotype names in Table 1. The DNA content of the amplified product was detected using a Qubit3.0 instrument.
1)PCR扩增体系:1) PCR amplification system:
表4:PCR扩增体系Table 4: PCR amplification system
2)PCR扩增程序:2) PCR amplification procedure:
95℃预变性3min;95℃变性30sec,56℃退火30sec,72℃延伸45sec,共25个循环;最后72℃延伸5min;4℃保存。Pre-denaturation at 95 °C for 3 min; denaturation at 95 °C for 30 sec, annealing at 56 °C for 30 sec, extension at 72 °C for 45 sec, a total of 25 cycles; final extension at 72 °C for 5 min; storage at 4 °C.
3)0.8X磁珠纯化方案:3) 0.8X magnetic bead purification scheme:
本发明产物纯化使用诺唯赞VAHTS DNAClean Beads,纯化前将磁珠液提前30min从2~8℃取出,静置使其温度平衡至室温。旋涡振荡使磁珠液充分混匀,吸取40μl磁珠液加入50μl DNA扩增产物中,使用移液器轻轻吸打10次充分混匀,室温孵育10min,使DNA结合到磁珠上。将样品置于磁力架上,待溶液澄清后(约5min),小心移除上清。保持样品始终处于磁力架上,加入200μl新鲜配制的80%乙醇漂洗磁珠,室温孵育30sec,小心移除上清。再次加入200μl新鲜配制的80%乙醇漂洗磁珠,室温孵育30sec,小心移除上清。保持样品始终处于磁力架上,室温下开盖干燥磁珠约5-10min。将样品从磁力架上取出,加入50μlNuclease-free Water,涡旋振荡或使用移液器吹打充分混匀,室温静置2min。在磁力架上静置5min待溶液澄清后,小心吸取上清至一个新的无核酸酶离心管中,做好标记待用。Novozyme VAHTS DNAClean Beads are used for the purification of the product of the present invention. Before purification, the magnetic bead solution is taken out from 2 to 8°
4)PCR产物质控4) PCR product quality control
表5:扩增产物质控结果Table 5: Amplification product quality control results
4.多位点标准品制备4. Multisite Standard Preparation
将以上6管扩增产物,制备成3管多位点标准品。混合方案如下表:The above 6 tubes of amplification products were prepared into 3 tubes of multi-site standards. The mixing scheme is as follows:
表6:多位点标准品混合方案表Table 6: Multisite Standard Mixing Protocol Table
使用Qubit3.0仪器检测制备好的标准品浓度,并将其稀释至10ng/μL待用。Use the Qubit3.0 instrument to detect the concentration of the prepared standard and dilute it to 10ng/μL for use.
5.基因分型验证5. Genotyping Validation
本发明使用ABI QuantStudio6实时荧光定量PCR仪,进行标准品基因分型验证实验,每个标准品做了三个重复。The present invention uses the ABI QuantStudio6 real-time fluorescence quantitative PCR instrument to carry out the standard product genotyping verification experiment, and each standard product is repeated three times.
1)基因分型体系:1) Genotyping system:
表7:标准品基因分型验证体系Table 7: Standard Genotyping Verification System
2)基因分型程序:2) Genotyping procedure:
Pre-Amp:60℃/30s,Amplication:95℃/10min;95℃/30s、60℃/1min*,40个循环;Post-Amp:60℃/30s。Pre-Amp: 60°C/30s, Amplication: 95°C/10min; 95°C/30s, 60°C/1min*, 40 cycles; Post-Amp: 60°C/30s.
3)基因分型结果:见图13) Genotyping results: see Figure 1
6.标准品持续使用方法6. Continuous use of standard products
本方案制备的标准品,通过融合引物扩增的方式,得到标准品SNP序列。融合引物结构包含两部分,一部分为标准品制备的通用引物序列,另一部分为SNP位点基因扩增引物序列。当标准品体积过少时,仅需取1ul标准品,使用标准品制备通用引物进行PCR扩增、纯化后即可继续使用。The standard product prepared in this scheme is amplified by fusion primers to obtain the SNP sequence of the standard product. The fusion primer structure consists of two parts, one part is the universal primer sequence prepared by the standard product, and the other part is the SNP site gene amplification primer sequence. When the volume of the standard product is too small, only 1ul of the standard product is needed, and the standard product is used to prepare universal primers for PCR amplification and purification, and then continue to use.
该发明的标准品,除了具有将多位点SNP每种基因各融合成一管,易于保存和使用的优势,还可通过简单的单引物PCR进行新一轮标准品的制备,使该标准品可持续使用。相比基因合成的方式制备标准品,大大降低了制备成本。In addition to the advantages of fusing each gene of multi-locus SNP into one tube, the standard product of the invention is easy to store and use, and a new round of standard product can be prepared by simple single-primer PCR, so that the standard product can be easily stored and used. Use continuously. Compared with the preparation of standard products by gene synthesis, the preparation cost is greatly reduced.
实施例2Example 2
1.SNP位点引物设计1. SNP site primer design
引物设计,可直接采用TaqMan探针或其他基于荧光定量PCR的检测平台探针产品自带的引物序列。也可通过rs号,获取其基因序列,使用引物设计软件或网站自行设计引物。For primer design, the primer sequences that come with TaqMan probes or other fluorescent quantitative PCR-based detection platform probe products can be directly used. The gene sequence can also be obtained through the rs number, and primers can be designed by using primer design software or website.
本发明采用Thermo Fisher TaqMan探针进行实验,引物直接选用Thermo FisherTaqMan探针产品自带的引物序列。详细信息同表1:Thermo Fisher TaqMan探针产品自带引物探针序列信息表。In the present invention, the Thermo Fisher TaqMan probe is used for the experiment, and the primers are directly selected from the primer sequences of the Thermo Fisher TaqMan probe product. The detailed information is the same as Table 1: Thermo Fisher TaqMan probe product comes with primer probe sequence information table.
2.样本准备2. Sample Preparation
三个SNP位点,每个SNP位点,各准备2种纯合基因型的样本,样本信息同表2样本信息表。Three SNP loci, for each SNP locus, two samples of homozygous genotypes were prepared, and the sample information was the same as the sample information table in Table 2.
3.SNP序列扩增3. SNP sequence amplification
使用对应的PCR扩增引物,分别将样本的SNP基因序列扩增下来,并进行0.8X磁珠纯化。完成纯化后,扩增产物名称与表1基因型名称一致。使用Qubit3.0仪器检测扩增产物DNA含量。Using the corresponding PCR amplification primers, the SNP gene sequences of the samples were amplified respectively, and purified by 0.8X magnetic beads. After purification, the names of the amplified products were consistent with the genotype names in Table 1. The DNA content of the amplified product was detected using a Qubit3.0 instrument.
1)PCR扩增体系见表3。1) The PCR amplification system is shown in Table 3.
表8:PCR扩增体系Table 8: PCR amplification system
2)PCR扩增程序:2) PCR amplification procedure:
95℃预变性3min;95℃变性30sec,56℃退火30sec,72℃延伸45sec,共25个循环;最后72℃延伸5min;4℃保存。Pre-denaturation at 95 °C for 3 min; denaturation at 95 °C for 30 sec, annealing at 56 °C for 30 sec, extension at 72 °C for 45 sec, a total of 25 cycles; final extension at 72 °C for 5 min; storage at 4 °C.
3)0.8X磁珠纯化方案:3) 0.8X magnetic bead purification scheme:
本发明产物纯化使用诺唯赞VAHTS DNAClean Beads,纯化前将磁珠液提前30min从2~8℃取出,静置使其温度平衡至室温。旋涡振荡使磁珠液充分混匀,吸取40μl磁珠液加入50μl DNA扩增产物中,使用移液器轻轻吸打10次充分混匀,室温孵育10min,使DNA结合到磁珠上。将样品置于磁力架上,待溶液澄清后(约5min),小心移除上清。保持样品始终处于磁力架上,加入200μl新鲜配制的80%乙醇漂洗磁珠,室温孵育30sec,小心移除上清。再次加入200μl新鲜配制的80%乙醇漂洗磁珠,室温孵育30sec,小心移除上清。保持样品始终处于磁力架上,室温下开盖干燥磁珠约5-10min。将样品从磁力架上取出,加入50μlNuclease-free Water,涡旋振荡或使用移液器吹打充分混匀,室温静置2min。在磁力架上静置5min待溶液澄清后,小心吸取上清至一个新的无核酸酶离心管中,做好标记待用。Novozyme VAHTS DNAClean Beads are used for the purification of the product of the present invention. Before purification, the magnetic bead solution is taken out from 2 to 8°
4)PCR产物质控4) PCR product quality control
表9:扩增产物质控结果Table 9: Amplification product quality control results
4.多位点标准品制备4. Multisite Standard Preparation
将以上6管扩增产物,制备成3管多位点标准品。混合方案如下表:The above 6 tubes of amplification products were prepared into 3 tubes of multi-site standards. The mixing scheme is as follows:
表10:多位点标准品混合方案表Table 10: Multisite Standard Mixing Protocol Table
使用Qubit3.0仪器检测制备好的标准品浓度,并将其稀释至10ng/μL待用。Use the Qubit3.0 instrument to detect the concentration of the prepared standard and dilute it to 10ng/μL for use.
5.标准品文库构建5. Standard Library Construction
本发明标准品文库构建采用VAHTSTM Universal DNALibrary Prep Kit forV3(ND607)试剂盒,通过末端修复、A接头连接、纯化、PCR扩增、产物纯化等过程,完成标准品文库构建。构建成功的标准品文库中,所有SNP序列均统一连接了illumina平台测序常用接头序列(图2)。后续标准品即将用完时,只需使用统一引物序列(表11)进行PCR扩增、纯化后,即可等到新一轮标准品,实现标准品可持续使用的目标。The standard product library of the present invention is constructed using VAHTSTM Universal DNALibrary Prep Kit for The V3(ND607) kit completes the standard library construction through the process of end repair, A-linker ligation, purification, PCR amplification, and product purification. In the successfully constructed standard library, all SNP sequences were uniformly connected to the commonly used linker sequences for sequencing on the illumina platform (Figure 2). When the follow-up standard is about to run out, just use the unified primer sequence (Table 11) for PCR amplification and purification, and then wait for a new round of standard to achieve the goal of sustainable use of the standard.
表11:标准品制备通用引物序列Table 11: Standard Preparation Universal Primer Sequences
6.基因分型验证6. Genotyping Validation
本发明使用ABI QuantStudio6实时荧光定量PCR仪,进行标准品基因分型验证实验,每个标准品做了三个重复。The present invention uses the ABI QuantStudio6 real-time fluorescence quantitative PCR instrument to carry out the standard product genotyping verification experiment, and each standard product is repeated three times.
1)基因分型体系见表7。1) The genotyping system is shown in Table 7.
2)基因分型程序:2) Genotyping procedure:
Pre-Amp:60℃/30s;Amplication:95℃/10min,95℃/30s、60℃/1min*、40个循环;Post-Amp:60℃/30s。Pre-Amp: 60°C/30s; Amplication: 95°C/10min, 95°C/30s, 60°C/1min*, 40 cycles; Post-Amp: 60°C/30s.
3)基因分型结果:见图33) Genotyping results: see Figure 3
7.标准品持续使用方法7. Continuous use of standard products
本方案制备的标准品,通过PCR产物文库构建的方式,得到具有统一接头序列的标准品文库。当标准品体积过少时,仅需取1ul标准品,使用标准品制备通用引物序列进行PCR扩增、纯化后即可继续使用。The standard products prepared in this scheme are constructed by PCR product library to obtain a standard product library with a unified linker sequence. When the volume of the standard product is too small, only 1ul of the standard product is needed, and the standard product is used to prepare universal primer sequences for PCR amplification and purification, and then continue to use.
本发明的标准品,除了具有将多位点SNP每种基因各融合成一管,易于保存和使用的优势,还可通过简单的单引物PCR进行新一轮标准品的制备,使该标准品可持续使用。相比基因合成的方式制备标准品,大大降低了制备成本。The standard product of the present invention has the advantages of fusing each gene of the multi-site SNP into one tube, which is easy to store and use, and can also prepare a new round of standard product through simple single-primer PCR, so that the standard product can be easily stored and used. Use continuously. Compared with the preparation of standard products by gene synthesis, the preparation cost is greatly reduced.
rs25487,rs1042522和rs1048943的基因序列如下:The gene sequences of rs25487, rs1042522 and rs1048943 are as follows:
>rs25487>rs25487
GAGATGGGAGTCTCGCTCTGTCACCCAGGCCAGAGTGCAGTGGCACGATTTTGGCTTCCAGGTTCAAGCGATTCTCCTGCCTCAGCCTTCCGAGTAACTGGGATTACAGGCGTGCGCCACCAAGCCCAGCTAATTTTTGTGTTTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTCGAACTTCTGACCTCAAGTGATCCACCTGCCTCAGCCTCCCAGAGTGCTGGGATTACAGGCGTGAGCCACTGCACCGGGACTCACTTTGAATGAATGAATATGGACCCTAACACTTGTTCTCCCACCCCTGAGTTTTTGCACAAACTGCTCCTCCAGCCTTTTCTGATAAGCAGGCTTCACAGAGCCCTCTGTGACCTCCCAGGCAGGTCCTCCTTCCCTCATCTGGAGTACCCCAGCCCCTGCCCCGCTCCTCTCAGTAGTCTGCTGGCTCTGGGCTGGGACCACCTGTGTTCTCCGCTGGCAGGCCCCAGTCTGACTCCCCTCCAGATTCCTGGCATTGCCCAGCACAGGATAAGGAGCAGGGTTGGCGTGTGAGGCCTTACCTCTGGGAGGGCAGCCGCCGACGCATGCGGTGACAGTCCAGCACCCACTCCTTACGCACGATGCGGCCTCCCAGGCCTAGGACCTGGCTGTACTTGGGGGTGTTGGCAAAGGCACAGCTGGTGGGGGGCAGAAGTGAAGATGCCAGTTAGGTGTGATCTGAGGGGCAAAGGGGAACGAGACAGGGGAGACAGACAGAGAGAGAGAGAGACAGACAGACAGACAGATCATGAGATTGAGGTGGGAGAAACAAAAAGAGGTTGGAGACCAAGGGAGAGATGCAAAAATCAGAGAGAAGACAAAGGCTACAGAATGCAGTGAGAAAGAAAGCAAGTGAGAGAGAGAGAAAGCATGCAGCATAGTGGACACAGAGAAAGCACAAGGTGGAGGAGACACAGGGAGCTGGGGGAGAAACTGCAGCGGCGCAGGGAGGGGGGCGCAAGCCTACATGAGGTGCGTGCTGTCCCGGGTCCAGTCTGGCCGATACTTGGCCCCAAGCTCTAGGGCCTTATCTCGCAGCTCGGAGCGGAAGGGGTTCTGGAAGCCACTCAGCACCACTACCACACCCTGAAGGATCTTCCCCAGCTCCTCTGGGCCAGCTCGGGGTCGTCTGGGCTCGGTGCCTTCTCCTCGGGGTTTGCCTGTCACTGCCCCCTGTGCTCGGGCAGGGACTGGAGATGGGAGTCTCGCTCTGTCACCCAGGCCAGAGTGCAGTGGCACGATTTTGGCTTCCAGGTTCAAGCGATTCTCCTGCCTCAGCCTTCCGAGTAACTGGGATTACAGGCGTGCGCCACCAAGCCCAGCTAATTTTTGTGTTTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTCGAACTTCTGACCTCAAGTGATCCACCTGCCTCAGCCTCCCAGAGTGCTGGGATTACAGGCGTGAGCCACTGCACCGGGACTCACTTTGAATGAATGAATATGGACCCTAACACTTGTTCTCCCACCCCTGAGTTTTTGCACAAACTGCTCCTCCAGCCTTTTCTGATAAGCAGGCTTCACAGAGCCCTCTGTGACCTCCCAGGCAGGTCCTCCTTCCCTCATCTGGAGTACCCCAGCCCCTGCCCCGCTCCTCTCAGTAGTCTGCTGGCTCTGGGCTGGGACCACCTGTGTTCTCCGCTGGCAGGCCCCAGTCTGACTCCCCTCCAGATTCCTGGCATTGCCCAGCACAGGATAAGGAGCAGGGTTGGCGTGTGAGGCCTTACCTCTGGGAGGGCAGCCGCCGACGCATGCGGTGACAGTCCAGCACCCACTCCTTACGCACGATGCGGCCTCCCAGGCCTAGGACCTGGCTGTACTTGGGGGTGTTGGCAAAGGCACAGCTGGTGGGGGGCAGAAGTGAAGATGCCAGTTAGGTGTGATCTGAGGGGCAAAGGGGAACGAGACAGGGGAGACAGACAGAGAGAGAGAGAGACAGACAGACAGACAGATCATGAGATTGAGGTGGGAGAAACAAAAAGAGGTTGGAGACCAAGGGAGAGATGCAAAAATCAGAGAGAAGACAAAGGCTACAGAATGCAGTGAGAAAGAAAGCAAGTGAGAGAGAGAGAAAGCATGCAGCATAGTGGACACAGAGAAAGCACAAGGTGGAGGAGACACAGGGAGCTGGGGGAGAAACTGCAGCGGCGCAGGGAGG GGGGCGCAAGCCTACATGAGGTGCGTGCTGTCCCGGGTCCAGTCTGGCCGATACTTGGCCCCAAGCTCTAGGGCCTTATCTCGCAGCTCGGAGCGGAAGGGGTTCTGGAAGCCACTCAGCACCACTACCACACCCTGAAGGATCTTCCCCAGCTCCTCTGGGCCAGCTCGGGGTCGTCTGGGCTCGGTGCCTTCTCCTCGGGGTTTGCCTGTCACTGCCCCCTGTGCTCGGGCAGGGACTG
>rs1042522>rs1042522
TATTTTTTTGTAGAGACGAGGTTTCATCATGTTACCCAGGCTGGTCTTGAACTCCTGGGCTCAGGTGATCTGCCTGCCTTGGCCTCTTTGAGAGTGCTGGGATTGCAGGTGTGAGCCACCAAGCCTGGTCAGGAGCTTATTTTCAAAAGCCAAGGAATACACGTGGATGAAGAAAAAGAAAAGTTCTGCATCCCCAGGAGAGATGCTGAGGGTGTGATGGGATGGATAAAAGCCCAAATTCAAGGGGGGAATATTCAACTTTGGGACAGGAGTCAGAGATCACACATTAAGTGGGTAAACTATAAAAAAACACTGACAGGAAGCCAAAGGGTGAAGAGGAATCCCAAAGTTCCAAACAAAAGAAATGCAGGGGGATACGGCCAGGCATTGAAGTCTCATGGAAGCCAGCCCCTCAGGGCAACTGACCGTGCAAGTCACAGACTTGGCTGTCCCAGAATGCAAGAAGCCCAGACGGAAACCGTAGCTGCCCTGGTAGGTTTTCTGGGAAGGGACAGAAGATGACAGGGGCCAGGAGGGGGCTGGTGCAGGGGCCGCCGGTGTAGGAGCTGCTGGTGCAGGGGCCACGGGGGGAGCAGCCTCTGGCATTCTGGGAGCTTCATCTGGACCTGGGTCTTCAGTGAACCATTGTTCAATATCGTCCGGGGACAGCATCAAATCATCCATTGCTTGGGACGGCAAGGGGGACTGTAGATGGGTGAAAAGAGCAGTCAGAGGACCAGGTCCTCAGCCCCCCAGCCCCCCAGCCCTCCAGGTCCCCAGCCCTCCAGGTCCCCAGCCCAACCCTTGTCCTTACCAGAACGTTGTTTTCAGGAAGTCTGAAAGACAAGAGCAGAAAGTCAGTCCCATGGAATTTTCGCTTCCCACAGGTCTCTGCTAGGGGGCTGGGGTTGGGGTGGGGGTGGTGGGCCTGCCCTTCCAATGGATCCACTCACAGTTTCCATAGGTCTGAAAATGTTTCCTGACTCAGAGGGGGCTCGACGCTAGGATCTGACTGCGGCTCCTCCATGGCAGTGACCCGGAAGGCAGTCTGGCTGCTGCAAGAGGAAAAGTGGGGATCCAGCATGAGACACTTCCAACCCTGGGTCACCTGGGCCTGCAGAGAAGGAACCCCCTCCCCCAATATTTTTTTGTAGAGACGAGGTTTCATCATGTTACCCAGGCTGGTCTTGAACTCCTGGGCTCAGGTGATCTGCCTGCCTTGGCCTCTTTGAGAGTGCTGGGATTGCAGGTGTGAGCCACCAAGCCTGGTCAGGAGCTTATTTTCAAAAGCCAAGGAATACACGTGGATGAAGAAAAAGAAAAGTTCTGCATCCCCAGGAGAGATGCTGAGGGTGTGATGGGATGGATAAAAGCCCAAATTCAAGGGGGGAATATTCAACTTTGGGACAGGAGTCAGAGATCACACATTAAGTGGGTAAACTATAAAAAAACACTGACAGGAAGCCAAAGGGTGAAGAGGAATCCCAAAGTTCCAAACAAAAGAAATGCAGGGGGATACGGCCAGGCATTGAAGTCTCATGGAAGCCAGCCCCTCAGGGCAACTGACCGTGCAAGTCACAGACTTGGCTGTCCCAGAATGCAAGAAGCCCAGACGGAAACCGTAGCTGCCCTGGTAGGTTTTCTGGGAAGGGACAGAAGATGACAGGGGCCAGGAGGGGGCTGGTGCAGGGGCCGCCGGTGTAGGAGCTGCTGGTGCAGGGGCCACGGGGGGAGCAGCCTCTGGCATTCTGGGAGCTTCATCTGGACCTGGGTCTTCAGTGAACCATTGTTCAATATCGTCCGGGGACAGCATCAAATCATCCATTGCTTGGGACGGCAAGGGGGACTGTAGATGGGTGAAAAGAGCAGTCAGAGGACCAGGTCCTCAGCCCCCCAGCCCCCCAGCCCTCCAGGTCCCCAGCCCTCCAGGTCCCCAGCCCAACCCTTGTCCTTACCAGAACGTTGTTTTCAGGAAGTCTGAAAGACAAGAGCAGAAAGTCAGTCCCATGGAATTTTCGCTTCCCACAGGTCTCTGCTAGGGGGCTGGGGTTGGGGTGGGGGTGGTGGGCCTGCCCTTCCAATGGATCCACTCACAGTTTCCATAGGTCTGAAAATGTTTCCTGACTCAGAGGGGGCTCGAC GCTAGGATCTGACTGCGGCTCCTCCATGGCAGTGACCCGGAAGGCAGTCTGGCTGCTGCAAGAGGAAAAGTGGGGATCCAGCATGAGACACTTCCAACCCTGGGTCACCTGGGCCTGCAGAGAAGGAACCCCCTCCCCCAA
>rs1048943>rs1048943
AGGGTCCTGGTTTGGCTAGTTCTAACTTGCTGAAGCCAGTCAG CACCCTCACAGAG CCAGCTAGGTACTGGGCCCAGGGGCTTCCAGAGAGTTCTTCAGAGCTTCTCAGAGGCCTAAGGACCTCCTAACCCTAGCAGG CCTCCTGGCTCAAGCACAACTTGGGAAGGCTCCATCAGCATCTATGTGGCCCTGTTTTACCTGTTGTCTCTGGAGGGTGTGCAGAGGCAAGTCCAGGGTAGGGGCAGGCAGGATCCCTTAGGCTTGCCCACAGCCCAGATAGCAAAACTGCAGCCAGATCAGTGTCTATGAGTTTCAGGCTGAACCTTAGACCACATAGGCCAGCCTGCTGGTCTGGCTGCCCAACCAGACCAGGTAGACAGAGTCTAGGCCTCAGGGCTCTCAAGCACCTAAGAGCGCAGCTGCATTTGGAAGTGCTCACAGCAGGCATG CTTCATGGTTAG CCCATAGATGGGGGTCATGTCCACCTTCACGCCCAGTGGCACGCTGAATTCCACCCGTTGCAGCAGGATAGCCAGGAAGAGAAAGACCTCCCAGCGGGCAATGGTCTCACCGATACACTTCCGCTTGCCCATGCCAAAGATAATCACCTTCTCACTTAACACCTTGTCGATAGCACCATCAGGGGTGAGAAACCGTTCAGGTAGGAACTCAGATGGGTTGACCCATAGCTTCCTGTAACCAGAGGGAGACAGCTGAAGTGGCAGTTCAGGGCTCAGAAGTGTCAAGTGAGTGGAGCTCCAGCCCCAAAGGATAGAGGACAGGCAAGCAGCCCATGGACAGGAGGATCAATGCAATGATTGTATTAATCATATATAAGAGCTTAAGAGGGTGGACCCAGCCTTTCCTCTGCATCTCTGAACTTACTGGTCATGGTTGATCTG CCACTGGTTTACAAAGACACAACGCCCCTTGGGGATGTAAAAGCCTTTCAAACTTGTGTCTCTTGTTGTGCTAGGGAGAAAGGAAGCTCAGTCAGGCTCAGGGCAACAGGCAAATCTCCCTGTCTCCCATGCCGTGTCCCTCCCACTAACCCTAATCAGGTATGTGGTCCGGAGTAAGATCAGTAACAGACAGCAGTGGCTCCATGGGGCCTTACCTGTGGGGGATGGTGAAGGGGACGAAGGAAGAGTGTCGGAAGGTCTCCAGGATGAAGGCCTCCATAAGGGTCCTGGTTTGGCTAGTTCTAACTTGCTGAAGCCAGTCAG CACCCTCACAGAG CCAGCTAGGTACTGGGCCCAGGGGCTTCCAGAGAGTTCTTCAGAGCTTCTCAGAGGCCTAAGGACCTCCTAACCCTAGCAGG CCTCCTGGCTCAAGCACAACTTGGGAAGGCTCCATCAGCATCTATGTGGCCCTGTTTTACCTGTTGTCTCTGGAGGGTGTGCAGAGGCAAGTCCAGGGTAGGGGCAGGCAGGATCCCTTAGGCTTGCCCACAGCCCAGATAGCAAAACTGCAGCCAGATCAGTGTCTATGAGTTTCAGGCTGAACCTTAGACCACATAGGCCAGCCTGCTGGTCTGGCTGCCCAACCAGACCAGGTAGACAGAGTCTAGGCCTCAGGGCTCTCAAGCACCTAAGAGCGCAGCTGCATTTGGAAGTGCTCACAGCAGGCATG CTTCATGGTTAG CCCATAGATGGGGGTCATGTCCACCTTCACGCCCAGTGGCACGCTGAATTCCACCCGTTGCAGCAGGATAGCCAGGAAGAGAAAGACCTCCCAGCGGGCAATGGTCTCACCGATACACTTCCGCTTGCCCATGCCAAAGATAATCACCTTCTCACTTAACACCTTGTCGATAGCACCATCAGGGGTGAGAAACCGTTCAGGTAGGAACTCAGATGGGTTGACCCATAGCTTCCTGTAACCAGAGGGAGACAGCTGAAGTGGCAGTTCAGGGCTCAGAAGTGTCAAGTGAGTGGAGCTCCAGCCCCAAAGGATAGAGGACAGGCAAGCAGCCCATGGACAGGAGGATCAATGCAATGATTGTATTAATCATATATAAGAGCTTAAGAGGGTGGACCCAGCCTTTCCTCTGCATCTCTGAACTTACTGGTCATGGTTGATCTG CCACTGGTTTACAAAGACACAACGCCCCTTGGGGATGTAAAAGCCTTTCAAACTTGTGTCTCTTGTTGTGCTAGGGAGAAAGGAAGCTCAGT CAGGCTCAGGGCAACAGGCAAATCTCCCTGTCTCCCATGCCGTGTCCCTCCCACTAACCCTAATCAGGTATGTGGTCCGGAGTAAGATCAGTAACAGACAGCAGTGGCTCCATGGGGCCTTACCTGTGGGGGATGGTGAAGGGGACGAAGGAAGAGTGTCGGAAGGTCTCCAGGATGAAGGCCTCCATA
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210230210.4A CN115125295A (en) | 2022-03-10 | 2022-03-10 | Genotyping standard substance for multi-site sustainable use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210230210.4A CN115125295A (en) | 2022-03-10 | 2022-03-10 | Genotyping standard substance for multi-site sustainable use |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115125295A true CN115125295A (en) | 2022-09-30 |
Family
ID=83376689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210230210.4A Pending CN115125295A (en) | 2022-03-10 | 2022-03-10 | Genotyping standard substance for multi-site sustainable use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115125295A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116445596A (en) * | 2023-06-09 | 2023-07-18 | 军科正源(北京)药物研究有限责任公司 | Product and method for human genotyping and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090029375A1 (en) * | 2007-07-11 | 2009-01-29 | Intergenetics, Inc. | Genetic models for stratification of cancer risk |
CN110205363A (en) * | 2019-05-24 | 2019-09-06 | 武汉大学 | Apolipoprotein E gene KASP parting detecting reagent and its method |
CN111808933A (en) * | 2020-06-23 | 2020-10-23 | 安徽微分基因科技有限公司 | Standard substance for illiminina second-generation sequencing platform |
CN113136433A (en) * | 2021-05-11 | 2021-07-20 | 浙江迪谱诊断技术有限公司 | Kit for simultaneously detecting multiple SNP sites related to tumor susceptibility |
-
2022
- 2022-03-10 CN CN202210230210.4A patent/CN115125295A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090029375A1 (en) * | 2007-07-11 | 2009-01-29 | Intergenetics, Inc. | Genetic models for stratification of cancer risk |
CN110205363A (en) * | 2019-05-24 | 2019-09-06 | 武汉大学 | Apolipoprotein E gene KASP parting detecting reagent and its method |
CN111808933A (en) * | 2020-06-23 | 2020-10-23 | 安徽微分基因科技有限公司 | Standard substance for illiminina second-generation sequencing platform |
CN113136433A (en) * | 2021-05-11 | 2021-07-20 | 浙江迪谱诊断技术有限公司 | Kit for simultaneously detecting multiple SNP sites related to tumor susceptibility |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116445596A (en) * | 2023-06-09 | 2023-07-18 | 军科正源(北京)药物研究有限责任公司 | Product and method for human genotyping and application thereof |
CN116445596B (en) * | 2023-06-09 | 2023-09-15 | 军科正源(北京)药物研究有限责任公司 | Product and method for human genotyping and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107109485B (en) | Universal blocking oligomer systems for multiple capture reactions and improved methods of hybrid capture | |
US20230250476A1 (en) | Deep Sequencing Profiling of Tumors | |
CN106591441B (en) | Alpha and/or beta-thalassemia mutation detection probe, method and chip based on whole gene capture sequencing and application | |
CN104372093B (en) | A kind of SNP detection method based on high-flux sequence | |
US20240158843A1 (en) | Accurate and massively parallel quantification of nucleic acid | |
CN101532051B (en) | A method for detecting ADH2 gene polymorphism | |
WO2019144582A1 (en) | Probe and method for high-throughput sequencing targeted capture target region used for detecting gene mutations as well as known and unknown gene fusion types | |
WO2014101655A1 (en) | Method for analyzing high-throughput nucleic acid and application thereof | |
Peng et al. | Whole genome amplification from single cells in preimplantation genetic diagnosis and prenatal diagnosis | |
WO2012089148A1 (en) | Method for single cell genome analysis and kit therefor | |
CN113278611B (en) | Capture Sequencing Probes and Their Uses | |
CN105624272A (en) | Construction method of genome presumptive area nucleic acid sequencing library and device thereof | |
CN102877136A (en) | Genome simplification and next-generation sequencing-based deoxyribose nucleic acid (DNA) library preparation method and kit | |
Ling et al. | Evaluation of genome coverage and fidelity of multiple displacement amplification from single cells by SNP array | |
CN103215366A (en) | Detection method for multi-genotyping based on isothermal signal amplification of nuclease and hairpin DNA (deoxyribonucleic acid) probe | |
Yao et al. | Blocker displacement amplification mediated PCR based screen-printed carbon electrode biosensor and lateral flow strip strategy for CYP2C19* 2 genotyping | |
CN116377082A (en) | Application of Single Nucleotide Polymorphism Markers of Sheep LCORL Gene in Selection of Growth Traits | |
CN115125295A (en) | Genotyping standard substance for multi-site sustainable use | |
CN110846408A (en) | Primer combination for detecting TTN gene mutation and its application | |
CN103270170B (en) | The method of HLA-DQB1 gene type and relevant primer thereof | |
CN113046349B (en) | SNP molecular marker combination for detecting rice Wx gene and application thereof | |
CN107937493A (en) | A kind of hair clip Mdification primer for allele PCR | |
Orkunoglu-Suer et al. | Targeted single molecule sequencing methodology for ovarian hyperstimulation syndrome | |
CN113234822A (en) | Method for capturing genetic colorectal cancer genome target sequence | |
Devesa-Peiró et al. | Molecular biology approaches utilized in preimplantation genetics: real-time PCR, microarrays, next-generation sequencing, karyomapping, and others |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |